Adzynma 500 I.E.

Adzynma 500 I.E. is a medicine authorised by Swissmedic under authorisation number 69562. The authorisation holder is Takeda Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 February 2026 and the authorisation is limited until 23 February 2031. ATC code B01AD13 places the medicine in the group Antithrombotic agents.

Dispensing category B
Authorisation number 69562
ATC B01AD13
Biotechnological medicines

Authorisation data
Authorisation number	69562
Name	Adzynma 500 I.E.
Full name	Adzynma 500 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Authorisation holder	Takeda Pharma AG
Medicinal product code	Biotechnological medicines
Dispensing category	B · Prescription only
ATC code	B01AD13
First authorisation	24 February 2026
Authorisation validity	23 February 2031

Strengths
No.	Name	Dispensing category	Authorisation date
1	Adzynma 500 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	B	24 February 2026
2	Adzynma 1500 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	B	24 February 2026

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	1 x 500	I.E.	B01AD13	06.99.0.	B
2	1 x 1500	I.E.	B01AD13	06.99.0.	B

Scroll the table sideways

Other medicines from this authorisation holder

Adcetris 50 mgAuthorisation number 62132 · ATC L01FX05A Advate 250 IE (5 ml)Authorisation number 56352 · ATC B02BD02B Adynovi 250 IE (5 ml)Authorisation number 65953 · ATC B02BD02B Agopton 30 mgAuthorisation number 51969 · ATC A02BC03B Alunbrig 30 mgAuthorisation number 66738 · ATC L01ED04A Ceprotin 500 I.E.Authorisation number 56124 · ATC B01AD12B Cinryze 500 IEAuthorisation number 61636 · ATC B06AC01B Cuvitru 200 mg/mlAuthorisation number 65992 · ATC J06BA01B

Frequently asked questions

Is Adzynma 500 I.E. authorised in Switzerland?

Yes. Adzynma 500 I.E. is authorised by Swissmedic under authorisation number 69562, data as of 01 September 2026. The authorisation is limited until 23 February 2031.

Which dispensing category does Adzynma 500 I.E. have?

Adzynma 500 I.E. is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Adzynma 500 I.E.?

The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.